Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration

被引:0
|
作者
J B Jonas
U H Spandau
B A Kamppeter
B Harder
机构
[1] Faculty of Clinical Medicine Mannheim of the University Heidelberg,Department of Ophthalmology
来源
Eye | 2007年 / 21卷
关键词
intravitreal triamcinolone acetonide; intravitreal steroids; age-related macular degeneration; intraocular neovascularization; macular disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:387 / 394
页数:7
相关论文
共 50 条
  • [21] Inter-eye difference in exudative age-related macular degeneration after unilateral intravitreal injection of triamcinolone acetonide
    Jonas, JB
    Spandau, UH
    Harder, B
    Vossmerbaeumer, U
    Kreissig, I
    Kamppeter, BA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [22] Evaluation of subretinal triamcinolone acetonide in patients with exudative age-related macular degeneration
    Kozak, Igor
    Cheng, Lingyun
    Falkenstein, Iryna
    Tammewar, Ajay M.
    Freeman, William R.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 23 (01) : 46 - 53
  • [23] Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study
    J B Jonas
    R F Degenring
    I Kreissig
    T Friedemann
    I Akkoyun
    Eye, 2005, 19 : 163 - 170
  • [24] Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study
    Jonas, JB
    Degenring, RF
    Kreissig, I
    Friedemann, T
    Akkoyun, I
    EYE, 2005, 19 (02) : 163 - 170
  • [25] Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
    Becerra, E. M.
    Morescalchi, F.
    Gandolfo, F.
    Danzi, P.
    Nascimbeni, G.
    Arcidiacono, B.
    Semeraro, F.
    CURRENT DRUG TARGETS, 2011, 12 (02) : 149 - 172
  • [26] Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration
    Jonas, JB
    Kreissig, I
    Degenring, RF
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (12) : 1557 - 1562
  • [27] Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema
    Jonas, J. B.
    Spandau, U. H.
    Kamppeter, B. A.
    Vossmerbaeumer, U.
    Harder, B.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2006, 16 (04) : 566 - 572
  • [28] Long-Term Follow-Up After Multiple Intravitreal Bevacizumab Injections for Exudative Age-Related Macular Degeneration
    Tao, Yong
    Libondi, Teodosio
    Jonas, Jost B.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (01) : 79 - 83
  • [29] Short-term visual outcome of exudative age-related macular degeneration treatment with intravitreal triamcinolone acetonide.
    Danis, RP
    Ciulla, TA
    Pratt, LM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S316 - S316
  • [30] Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up
    Challa, JK
    Gillies, MC
    Penfold, PL
    Gyory, JF
    Hunyor, ABL
    Billson, FA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1998, 26 (04): : 277 - 281